WebTematel-A once-daily produces effective and consistent reductions in blood pressure across the 24-hour therapeutic dose range. Telmisartan (Tematel-A): Telmisartan (Tematel-A) … WebTematel H 80mg Tablet belongs to the therapeutic classification of Diuretic Agents, Angiotensin II Receptor Blockers. The primary composition for this medicine is Telmisartan 80 MG, Hydrochlorothiazide 12.5 MG. Tematel H 80mg Tablet is manufactured in India by Curis Lifecare. This medicine is available in the form of Tablet.
Tematel H 80mg Tablet - Uses, Dosage, Side Effects
WebTematel 40mg Tablet belongs to the therapeutic classification of Angiotensin II Receptor Blockers. The primary composition for this medicine is Telmisartan 40 MG. Tematel 40mg Tablet is manufactured in India by Curis Lifecare. This medicine is … WebGeneral Considerations. Telmisartan (Tematel-A) is an effective treatment of hypertension in once daily doses of 20 to 80 mg while Amlodipine (Tematel-A) is effective in doses of 2.5 to 10 mg. Dosage must be individualized and may be increased after at least 2 weeks. Most of the antihypertensive effect is apparent within 2 weeks and maximal reduction is … merit increase justification examples
TEMATEL - mims.com
WebTematel 80mg Tablet is a medicine used to treat high blood pressure and heart failure. Lowering blood pressure helps to prevent future heart attack and stroke. This medicine is also effective in preserving kidney function in patients with diabetes. WebTematel H 40mg Tablet belongs to the therapeutic classification of Diuretic Agents, Angiotensin II Receptor Blockers. The primary composition for this medicine is Telmisartan 40 MG, Hydrochlorothiazide 12.5 MG. Tematel H 40mg Tablet is manufactured in India by Curis Lifecare. This medicine is available in the form of Tablet. WebFixed-Dose Combination: The safety and tolerability of Tematel-A has been evaluated in five controlled clinical studies with over 3500 patients, over 2500 of whom received Telmisartan (Tematel-A) in combination with Amlodipine (Tematel-A). Adverse reactions reported in clinical trials with Telmisartan (Tematel-A) plus Amlodipine (Tematel-A) are shown as … merit increase process and guidelines